Abstract: To provide a glycyrrhizin/aminoacetic acid/cysteine combination drug containing an active ingredient in high concentration and excelling in stability and safety. Stability at compounding of active ingredient in high concentration has been improved by avoiding the addition of sulfite salts having been used as a stabilizer in existing products. As glycyrrhizin high-concentration preparations, there is provided a drug composition comprising 8 to 16 mg/mL of glycyrrhizin, 3 to 6 mg/mL of cysteine and 80 to 160 mg/mL of aminoacetic acid wherein no sulfite salts are added as an additive, and pH is 6 to 7.

Abstract: An enveloping device (1), capable of repeatedly performing a process for producing an envelope and inserting a content into the envelope at high speed, comprises: a film feeder (2) for feeding a film (7) wound on a roll and supplied in the form of two overlapping folds that extend in a width direction (W); an envelope making device (3) for repeatedly forming an envelope by cutting and fusing, in a longitudinal direction of the film (7), the two overlapping folds while conveying the film; an envelope conveying conveyor (5) which conveys a plurality of envelopes (8) while arranging these envelopes in a line; and an inserting device (6) for inserting a content (9) into each envelope (8) conveyed by the envelope conveyor (5).

Abstract: An enveloping device (1) capable of successively performing a process for producing an envelope and inserting a content into the envelope at high speed comprises: film feeding means (2) for feeding a film (7) wound in the form of a roll in a shape overlapping in two folds in the middle of a width direction indicated by an arrow W; an envelope making device (3) for successively forming an envelope by fusing the middle of a longitudinal direction of the film (7) overlapping in two folds while conveying the film; envelope conveying means (5) which is a conveyor for conveying a plurality of envelopes (8) while arranging the envelopes in a line; and an inserting device (6) for inserting contents (9) into the envelopes (8) conveyed by the envelope conveying means (5).

Abstract: To provide a glycyrrhizin/aminoacetic acid/cysteine combination drug containing an active ingredient in high concentration and excelling in stability and safety. Stability at compounding of active ingredient in high concentration has been improved by avoiding the addition of sulfite salts having been used as a stabilizer in existing products. As glycyrrhizin high-concentration preparations, there is provided a drug composition comprising 8 to 16 mg/mL of glycyrrhizin, 3 to 6 mg/mL of cysteine and 80 to 160 mg/mL of aminoacetic acid wherein no sulfite salts are added as an additive.